Our U.S. Presence
Advancing America’s Leadership in Cancer Treatment Innovation
1,800+
1.8M+
$1.84B
~$750MPipeline & Innovation
Delivering One of the Largest and Most Compelling Oncology Pipelines
Focus Areas:
Blood Cancers
Lung Cancers
Gastrointestinal Cancers
Breast & Gynecologic Cancers
Rare & Other Cancers
Advancing Cancer Research Across America
Clinical Trials Fuel Our Innovation for Cancer Patents
90+
900+
2,700+Collaborations
Expanding Patient Access & Building Collaborations for Better Health
At BeOne, we’re committed to ensuring patients can access innovative cancer treatments while working closely with partners to improve outcomes for patients across the U.S.
7,000+
60+
55+Strategic U.S. Sites Driving Innovation and Patient Impact
Hopewell, NJ U.S. Biologics Manufacturing and Clinical R&D Facility
311 Pennington-Rocky Hill Rd., Bldg 51 – Ste 1358
Pennington, NJ 08534
Our flagship U.S. biologics manufacturing and clinical R&D facility spans 42 acres and 400,000 square feet at the Princeton West Innovation Campus. This state-of-the-art site expands BeOne’s domestic capacity and strengthens our global ability to deliver innovative medicines.
San Carlos, CA Biomarker Laboratory
835 Industrial Rd, 6th Floor
San Carlos, CA 94070
A West Coast hub for innovation and collaboration, our San Carlos facility is home to our state-of-the-art biomarker laboratory equipped for next-generation sequencing, mass spectrometry, histology, immunoassays, and flow cytometry — accelerating translational research and early development programs.
Cambridge, MA Office
55 Cambridge Parkway, Suite 700W
Cambridge, MA 02142
Located in Boston’s world-class biotech ecosystem, our Cambridge office fosters U.S. and global connections that support innovation and patient impact.
Join Us in Transforming Cancer Care
